When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Последний просмотренный: 22 Oct 2026
Last updated: 19 May 2026

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • shortness of breath and fatigue
  • lymphadenopathy
  • splenomegaly
  • hepatomegaly

Факторы риска

  • age over 60 years
  • male sex
  • white ethnicity
  • family history of CLL

Диагностические исследования

Исследования, проведение которых нужно рассмотреть

  • serum beta-2 microglobulin
  • fluorescent in situ hybridization (FISH)
  • molecular genetic tests
  • direct antiglobulin test (DAT)
  • serum quantitative immunoglobulin
  • CT scan/fluorodeoxyglucose (FDG)-PET/CT

Алгоритм лечения

Составители

Авторы

Jacqueline C. Barrientos, MD, MS

Associate Professor

Department of Medicine

Zucker School of Medicine at Hofstra/Northwell

CLL Research & Treatment Program

Northwell Health Cancer Institute

Lake Success, NY

Раскрытие информации

JCB has been a consultant for Beigene, Abbvie, and AstraZeneca; received honoraria from Janssen; and received research funding from Oncternal, VelosBio, and Pharmacyclics.

Joanna M. Rhodes, MD, MSCE

Assistant Professor

Department of Medicine

Zucker School of Medicine at Hofstra/Northwell

CLL Research and Treatment Program

Northwell Health Cancer Institute

Lake Success, NY

Раскрытие информации

JMR has received consulting fees from AbbVie, ADC Therapeutics, AstraZeneca, BeOne, BMS, Epizyme, Genentech, GenMab, Janssen, Johnson & Johnson, MorphoSys, Pharmacyclics, Seagen, TG Therapeutics, Verastem, Pfizer, and Incyte. JMR’s institution has received research support from AbbVie, Acerta, ADC Therapeutics, AstraZeneca, Acrotech, BeOne, Janssen, Johnson & Johnson, Loxo Oncology, Oncternal Therapeutics, Pharmacyclics, VelosBio, and Merck.

Выражение благодарностей

Dr Jacqueline C. Barrientos and Dr Joanna M. Rhodes would like to gratefully acknowledge Dr Vidhya Murthy, Dr Shankaranarayana Paneesha, and Dr Robert Chen, previous contributors to this topic.

Раскрытие информации

VM has received a consultancy fee from Janssen, and a grant from Takeda for the ASH Annual Meeting 2014. SP has received consultancy and speaker fees from Janssen, Gilead, AbbVie, Bristol-Myers Squibb, and Takeda. RC declares that he has no competing interests.

Рецензенты

Alessandra Ferrajoli, MD

Associate Medical Director, Professor

Department of Leukemia Center

The University of Texas MD Anderson Cancer Center

Houston, TX

Раскрытие информации

AF declares that she has no competing interests.

Farrukh Awan, MD

Professor of Medicine

Department of Internal Medicine

UT Southwestern Medical Center

Dallas, TX

Раскрытие информации

FA declares that he has no competing interests.

Paolo F. Caimi, MD

Associate Professor

Department of Medicine

Case Western Reserve University

Case Comprehensive Cancer Center

Cleveland, OH

Раскрытие информации

PFC has received honoraria from Celgene for participation in a speaker bureau, and from Kite Pharma for participation in an advisory board.

Daniel Catovsky, MD, FRCP, FRCPath, DSc, FMedSc

Consultant Haemato-oncologist

Section of Haemato-Oncology

The Institute of Cancer Research

Sutton

UK

Раскрытие информации

Unfortunately, we have since been made aware that DC is deceased

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 Jun 21;131(25):2745-60.Полный текст  Аннотация

Walewska R, Parry-Jones N, Eyre TA, et al. Guideline for the treatment of chronic lymphocytic leukaemia. Br J Haematol. 2022 Jun;197(5):544-57.Полный текст  Аннотация

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: chronic lymphocytic leukemia/small lymphocytic lymphoma [internet publication].Полный текст

Eichhorst B, Robak T, Montserrat E, et al; ESMO Guidelines Committee. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Jan;32(1):23-33.Полный текст  Аннотация

Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021 Dec 1;96(12):1679-705.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available here.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности